Literature DB >> 33382982

Definition of a small core transcriptional circuit regulated by AML1-ETO.

Kristy R Stengel1, Jacob D Ellis2, Clare L Spielman2, Monica L Bomber2, Scott W Hiebert3.   

Abstract

Transcription factors regulate gene networks controlling normal hematopoiesis and are frequently deregulated in acute myeloid leukemia (AML). Critical to our understanding of the mechanism of cellular transformation by oncogenic transcription factors is the ability to define their direct gene targets. However, gene network cascades can change within minutes to hours, making it difficult to distinguish direct from secondary or compensatory transcriptional changes by traditional methodologies. To overcome this limitation, we devised cell models in which the AML1-ETO protein could be quickly degraded upon addition of a small molecule. The rapid kinetics of AML1-ETO removal, when combined with analysis of transcriptional output by nascent transcript analysis and genome-wide AML1-ETO binding by CUT&RUN, enabled the identification of direct gene targets that constitute a core AML1-ETO regulatory network. Moreover, derepression of this gene network was associated with RUNX1 DNA binding and triggered a transcription cascade ultimately resulting in myeloid differentiation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AML1-ETO; PRO-seq; PROTAC; RUNX1; RUNX1T1; degron tag; myeloid leukemia; nascent transcription

Mesh:

Substances:

Year:  2020        PMID: 33382982      PMCID: PMC7867650          DOI: 10.1016/j.molcel.2020.12.005

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  76 in total

1.  Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element.

Authors:  James C Mulloy; Jorg Cammenga; Francisco J Berguido; Kaida Wu; Ping Zhou; Raymond L Comenzo; Suresh Jhanwar; Malcolm A S Moore; Stephen D Nimer
Journal:  Blood       Date:  2003-08-28       Impact factor: 22.113

2.  Targeted in situ genome-wide profiling with high efficiency for low cell numbers.

Authors:  Peter J Skene; Jorja G Henikoff; Steven Henikoff
Journal:  Nat Protoc       Date:  2018-04-12       Impact factor: 13.491

3.  Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.

Authors:  Eric Jourdan; Nicolas Boissel; Sylvie Chevret; Eric Delabesse; Aline Renneville; Pascale Cornillet; Odile Blanchet; Jean-Michel Cayuela; Christian Recher; Emmanuel Raffoux; Jacques Delaunay; Arnaud Pigneux; Claude-Eric Bulabois; Céline Berthon; Cécile Pautas; Norbert Vey; Bruno Lioure; Xavier Thomas; Isabelle Luquet; Christine Terré; Philippe Guardiola; Marie C Béné; Claude Preudhomme; Norbert Ifrah; Hervé Dombret
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

4.  Sequence specificity of the core-binding factor.

Authors:  I N Melnikova; B E Crute; S Wang; N A Speck
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

5.  The dTAG system for immediate and target-specific protein degradation.

Authors:  Behnam Nabet; Justin M Roberts; Dennis L Buckley; Joshiawa Paulk; Shiva Dastjerdi; Annan Yang; Alan L Leggett; Michael A Erb; Matthew A Lawlor; Amanda Souza; Thomas G Scott; Sarah Vittori; Jennifer A Perry; Jun Qi; Georg E Winter; Kwok-Kin Wong; Nathanael S Gray; James E Bradner
Journal:  Nat Chem Biol       Date:  2018-03-26       Impact factor: 15.040

6.  Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons.

Authors:  Iris Jonkers; Hojoong Kwak; John T Lis
Journal:  Elife       Date:  2014-04-29       Impact factor: 8.140

7.  RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML.

Authors:  Justin Loke; Salam A Assi; Maria Rosaria Imperato; Anetta Ptasinska; Pierre Cauchy; Yura Grabovska; Natalia Martinez Soria; Manoj Raghavan; H Ruud Delwel; Peter N Cockerill; Olaf Heidenreich; Constanze Bonifer
Journal:  Cell Rep       Date:  2017-05-23       Impact factor: 9.423

8.  RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

Authors:  Anetta Ptasinska; Anna Pickin; Salam A Assi; Paulynn Suyin Chin; Luke Ames; Roberto Avellino; Stephan Gröschel; Ruud Delwel; Peter N Cockerill; Cameron S Osborne; Constanze Bonifer
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

9.  TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.

Authors:  H-A Hou; W-C Chou; Y-Y Kuo; C-Y Liu; L-I Lin; M-H Tseng; Y-C Chiang; M-C Liu; C-W Liu; J-L Tang; M Yao; C-C Li; S-Y Huang; B-S Ko; S-C Hsu; C-Y Chen; C-T Lin; S-J Wu; W Tsay; Y-C Chen; H-F Tien
Journal:  Blood Cancer J       Date:  2015-07-31       Impact factor: 11.037

10.  Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal.

Authors:  Anetta Ptasinska; Salam A Assi; Natalia Martinez-Soria; Maria Rosaria Imperato; Jason Piper; Pierre Cauchy; Anna Pickin; Sally R James; Maarten Hoogenkamp; Dan Williamson; Mengchu Wu; Daniel G Tenen; Sascha Ott; David R Westhead; Peter N Cockerill; Olaf Heidenreich; Constanze Bonifer
Journal:  Cell Rep       Date:  2014-09-18       Impact factor: 9.423

View more
  12 in total

1.  Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells.

Authors:  Stuti Mehta; Altantsetseg Buyanbat; Yan Kai; Ozge Karayel; Seth Raphael Goldman; Davide Seruggia; Kevin Zhang; Yuko Fujiwara; Katherine A Donovan; Qian Zhu; Huan Yang; Behnam Nabet; Nathanael S Gray; Matthias Mann; Eric S Fischer; Karen Adelman; Stuart H Orkin
Journal:  Cell Chem Biol       Date:  2022-07-14       Impact factor: 9.039

Review 2.  Generating specificity in genome regulation through transcription factor sensitivity to chromatin.

Authors:  Luke Isbel; Ralph S Grand; Dirk Schübeler
Journal:  Nat Rev Genet       Date:  2022-07-12       Impact factor: 59.581

3.  LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML.

Authors:  Qian Chen; Murat A Cevher; Qi Jiang; Saisai Wang; Xiaojian Sun; Robert G Roeder; Mo Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

4.  [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].

Authors:  Y Wen; S Fang; J Yang; H Wang; Y Jiao; N Wang; Y Wei; L Wang; L Dou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

5.  MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape.

Authors:  Sarah Naomi Olsen; Laura Godfrey; James P Healy; Yoolim A Choi; Yan Kai; Charles Hatton; Florian Perner; Elena L Haarer; Behnam Nabet; Guo-Cheng Yuan; Scott A Armstrong
Journal:  Mol Cell       Date:  2022-03-03       Impact factor: 19.328

6.  Gene-specific quantification of nascent transcription following targeted degradation of endogenous proteins in cultured cells.

Authors:  Alissa D Guarnaccia; April M Weissmiller; William P Tansey
Journal:  STAR Protoc       Date:  2021-12-08

7.  Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice.

Authors:  Roberto Avellino; Roger Mulet-Lazaro; Marije Havermans; Remco Hoogenboezem; Leonie Smeenk; Nathan Salomonis; Rebekka K Schneider; Elwin Rombouts; Eric Bindels; Lee Grimes; Ruud Delwel
Journal:  Blood Adv       Date:  2022-03-08

8.  A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia.

Authors:  Taku Harada; Yaser Heshmati; Jérémie Kalfon; Monika W Perez; Juliana Xavier Ferrucio; Jazmin Ewers; Benjamin Hubbell Engler; Andrew Kossenkov; Jana M Ellegast; Joanna S Yi; Allyson Bowker; Qian Zhu; Kenneth Eagle; Tianxin Liu; Yan Kai; Joshua M Dempster; Guillaume Kugener; Jayamanna Wickramasinghe; Zachary T Herbert; Charles H Li; Jošt Vrabič Koren; David M Weinstock; Vikram R Paralkar; Behnam Nabet; Charles Y Lin; Neekesh V Dharia; Kimberly Stegmaier; Stuart H Orkin; Maxim Pimkin
Journal:  Genes Dev       Date:  2022-03-17       Impact factor: 12.890

9.  A protocol for rapid degradation of endogenous transcription factors in mammalian cells and identification of direct regulatory targets.

Authors:  Hillary M Layden; Nicholas A Eleuteri; Scott W Hiebert; Kristy R Stengel
Journal:  STAR Protoc       Date:  2021-05-19

Review 10.  Core binding factor acute myelogenous leukemia-2021 treatment algorithm.

Authors:  Gautam Borthakur; Hagop Kantarjian
Journal:  Blood Cancer J       Date:  2021-06-16       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.